Industry questions Danish medicine stockpile mandate

The Danish pharma trade group Lif is calling for a formal evaluation of Denmark’s rules on mandatory stockpiles of “critical” medicines, arguing the requirements have increased administrative burden while leaving unanswered whether the policy has improved supply security for patients.

In a statement, Lif research policy head Anders Hoff pointed to a new account from the Danish Medicines Agency to the Danish parliament’s health committee showing that more than one in three companies covered by the regime have applied for exemptions from parts of the rules.